Philippe Amouyal
CIK: 0001376854
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 22, 2026CAVA
CAVA GROUP, INC.
Award(A)Direct1.9K shares- - Jun 3, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Exercise(M)Direct89.3K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
35.7K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
43.5K shares- - Jun 20, 2025CAVA
CAVA GROUP, INC.
Award(A)Direct1.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
103.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
89.3K shares- - May 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Exercise(M)Direct36.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  CAVA CAVA GROUP, INC. | Award(A) | 1,881 | - | $0 | Direct |
| Jun 3, 2026 |  LXRX LEXICON PHARMACEUTICALS, INC. | Exercise(M) | 89,312 | - | $0 | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 35,714 | - | - | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 43,478 | - | - | Direct |
| Jun 20, 2025 | CAVA CAVA GROUP, INC. | Award(A) | 1,767 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 103,806 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 89,312 | - | - | Direct |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise(M) | 36,810 | - | - | Direct |
1-8 of 8 transactions
About Amouyal Philippe
Amouyal Philippe (SEC CIK 0001376854) files insider reports with the SEC as Director of CAVA GROUP, INC. (CAVA) and Director of LEXICON PHARMACEUTICALS, INC. (LXRX).
Signal8 holds 6 ownership filings by Amouyal Philippe, all Form 4s, filed between May 13, 2025 and Jun 24, 2026. Those filings report 8 transactions, from May 13, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Amouyal Philippe's filings is in THE WOODLANDS, TX.
Recent filings by Amouyal Philippe
- Jun 22, 2026: Grant or award of CAVA shares (Form 4, code A).
- Jun 3, 2026: Option exercise of LXRX shares (Form 4, code M).
- May 1, 2026: Grants or awards of LXRX derivative securities (2 lines, Form 4, code A).
- Jun 20, 2025: Grant or award of CAVA shares (Form 4, code A).
- Jun 3, 2025: Grants or awards of LXRX derivative securities (2 lines, Form 4, code A).
Other insiders filing for CAVA GROUP, INC. (CAVA)
- KADOW JOSEPH JOHN, CLO & Secretary
- Xenohristos Theodoros, Chief Concept Officer
- Thompson Douglas W., Chief Operations Officer
- Thomas Amiee Lynn, Director
- Bosserman David, Director
- SHAICH RONALD M, Director